ArticleACS medicinal chemistry letters2020

Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic Therapy.

Daniel E Jeffries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.